
Trial Evaluates Gemcitabine, S-1, and Radiation for Advanced Pancreatic Cancer
A Phase 2 clinical trial reports survival and surgical resection outcomes for patients receiving the GSRT protocol.
Independent health-science reporting · Evidence ratedEvidence rated
Section
Trial openings, protocol designs, endpoint choices, and enrollment realities — including the trials patients and clinicians should know are recruiting now.

A Phase 2 clinical trial reports survival and surgical resection outcomes for patients receiving the GSRT protocol.

A review paper outlines the key regulatory and quality considerations needed to transition targeted cancer therapies from early clinical trials to commercial-scale production.

The HYPERBOLIC trial evaluates whether adding short-course chemotherapy to cemiplimab mitigates the risk of hyperprogressive disease in biomarker-selected lung cancer patients.

A correction notice has been registered for a phase II trial evaluating neoadjuvant paclitaxel-carboplatin followed by surgery.